The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of NALIRIFOX (nanoliposomal irinotecan + oxaliplatin with fluorouracil and folinic acid) in advanced unresectable small bowel tumors.
 
Tiago Biachi de Castria
Consulting or Advisory Role - AstraZeneca; Bayer; Moderna Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Astellas Pharma (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Ipsen; Moderna Therapeutics
 
Angela Alistar
No Relationships to Disclose
 
Brian Johnson
No Relationships to Disclose
 
Yolande Chen
No Relationships to Disclose
 
Victoria Chung
No Relationships to Disclose
 
Emily Kinsey
Consulting or Advisory Role - AstraZeneca; Cardinal Health
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Nikolaos Andreatos
Research Funding - Abbvie (Inst); Ipsen (Inst); Janssen Research & Development (Inst); Takeda (Inst)
 
Richard Kim
Honoraria - Natera
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Eisai; Exelixis; Jazz Pharmaceuticals; Pfizer; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - AstraZeneca; Incyte